Firms

8VC

Austin, Texas, US

8vc.com

signal.nfx.com

goldi.ai

Austin-headquartered technology investment and company-building firm founded in2015, with San Francisco and New York offices. Thesis areas include infrastructure IT, biology, healthcare, government/defense and logistics. Wispr historical neural-interface backing differs from its current voice AI products.

Founded: 2015
Type: Venture capital

Funds5

8VC Fund VII, L.P.2026-06-292026-06-29—
USD1.5B offering target from filing mirror; initial firstsale yettooccur, zero investors/sold at June filing. SECindex verifiesvehicle/date but underlyingbody unread. Later currentclose unverified; aggregatormid2026close claim notaccepted.
8VC Fund VI2025-03-042025-03-04$998M
Official newLPcapital announced; separate legal finalclosedate notidentified.
8VC Fund V2023-03-012023-03-01$880M
Announced newfund capital, distinct from manager >USD6B committedcapital.
8VC Fund IV2021-06-142021-06-14—
SEC Form D lists a USD640m offering with zero sold as of the filing. Closed size is unverified; amount is intentionally blank.
8VC Fund II2018-04-242018-04-24$640M
Second flagship fund; reported final size USD640m.

Team

Investments

team@apexlogos.ai13 minutes ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities. Fund size and capital status | Vehicle/measure | Amount, date and status | Evidence and qualification | | --- | --- | --- | | 8VC Fund V | **US$880 million**, announced 2023-03-01 as new fund capital | [Official Fund V announcement](https://www.8vc.com/resources/announcing-8vc-fund-v). A realized fundraising announcement, not merely a target. Announcement does not specify a separate legal final-close date. | | Aggregate committed capital | **Over US$6 billion**, as of 2023-03-01 | Same announcement. Manager-wide committed capital; not Fund V size and not necessarily current NAV or current regulatory AUM. | | 8VC Fund VI | **US$998 million** new LP capital, announced 2025-03-04 | [Official Fund VI announcement](https://8vc.com/resources/announcing-8vc-fund-vi). Treat as announced raised capital; no separate final-close date identified. Latest officially announced flagship raised amount verified here. | | 8VC Fund VII, L.P. | **US$1.5 billion offering target**; June 29, 2026 initial filing reports first sale yet to occur, zero investors and no sold capital | [SEC filing index](https://www.sec.gov/Archives/edgar/data/2128986/000212898626000001/0002128986-26-000001-index.htm) confirms issuer and filing date. [FormDs mirror](https://www.formds.com/issuers/8vc-fund-vii-l-p) supplies the offering/sold fields through search-index extraction. SEC underlying HTML/XML body could not be read through this browser. Do not label $1.5 billion closed. | Searches for a newer flagship found Fund VII, not an official close announcement. [StartupDB](https://startupdb.com/organizations/8vc) claims a $1.5 billion mid-2026 close and [VCSpine](https://www.vcspine.com/firms/8vc) describes June 2026 as a close while also showing $1.50 billion **offered**. These undated aggregator claims conflict with the as-filed pre-sale evidence; neither was accepted as closure verification. The June snapshot does not establish fundraising status on October 6. A newer amendment or firm/LP confirmation remains necessary. Other similarly numbered 8VC AI and Entrepreneurs vehicles exist; their names alone do not establish that they are the flagship VII or that their capital may be added without overlap. This memo does not claim a comprehensive total of all feeder/SPV capital. No current verified firm-wide AUM or check-size mandate found. Additional fund evidence checked in the final pass: - 8VC Fund II: [source](https://www.svb.com/globalassets/library/images/content/trends_and_insights/reports/venture_monitor_report/2q-2018/2q_2018_pitchbook_nvca_venture_monitor.pdf). - 8VC Fund IV: [source](https://www.sec.gov/Archives/edgar/data/1866729/000186672921000001/xslFormDX01/primary_doc.xml). Funds recorded in Adex after this review: | Fund | Disclosed amount | Announcement / filing date | | --- | --- | --- | | 8VC Fund II | USD 640000000 | 2018-04-24 | | 8VC Fund IV | Undisclosed / unverified | 2021-06-14 | | 8VC Fund V | USD 880000000 | 2023-03-01 | | 8VC Fund VI | USD 998000000 | 2025-03-04 | | 8VC Fund VII, L.P. | Undisclosed / unverified | 2026-06-29 |
team@apexlogos.ai1 hour ago
Match research 2026-10-06 / Firm8VC / sha256:d71c7626bfe56a833a8f42e2492f0b0569532f2fc5ecfa34d0c3864a01d0f6e4 / part 2 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. | **Saronic** | Autonomous surface vessels integrating maritime hardware, software and AI for mission autonomy and security. | [Official 8VC portfolio page](https://www.8vc.com/companies/saronic) (undated) lists Saronic, Series D and **8VC Fund IV**; this is direct firm portfolio/fund attribution, not independent round confirmation. [8VC Build page](https://www.8vc.com/build?76e3aeec_page=1) (undated) describes developing the concept with defense entrepreneur-in-residence Dino Mavrookas. No transaction date or amount inferred from its live stage field. | | **Wispr AI / Wispr Flow** | Historical AI-enabled non-invasive neural-interface wearable research; distinct from present speech software. | **8VC co-led $4.6 million seed**, **2021-11-30**, with NEA. See the neurotech analysis below. | Historical Oculus claims in 8VC marketing reach back to 2011, before the firm's 2015 founding field. Those were not promoted to verified present-firm fund investments. No Paradromics investment by 8VC was verified in the sources checked; search proximity or another investor's portfolio cannot establish attribution. ## Previous neurotech investment and current-status caveat **Wispr AI is a verified historical direct neurotechnology investment by 8VC.** Its [company-issued seed release](https://www.prnewswire.com/news-releases/wispr-ai-secures-4-6m-from-nea-and-8vc-to-build-thought-powered-neural-interface-301433912.html), dated **2021-11-30**, names 8VC and NEA as co-leads of $4.6 million and describes a wearable intended to decode deliberate thought. The [8VC investment article](https://8vc.com/resources/working-at-the-speed-of-thought-investing-in-wispr-ai), dated **2022-01-15**, independently confirms the co-lead role and specifically describes a non-invasive AI/neurotechnology interface. Attribution is to the firm, not merely a partner's angel check. The funding total is not 8VC's ticket. This confirms investment in a neural-interface development ambition, **not proof of direct cortical recording, a medically approved BCI, or a commercial thought-reading product**. The early marketing broadly uses BCI terminology without resolving neural signal modality or clinical validation. It should remain historical and technically qualified. The [current company Series B post](https://wisprflow.ai/post/series-b), dated **2026-08-17**, describes **$280 million Series B at $2 billion valuation**, current Flow voice-to-text/meeting products and proprietary speech models. That technology is speech AI, so this later financing is not independently evidence of ongoing neural-interface commercialization. The post names leaders/new investors but does not provide a complete returning-investor roster including 8VC; the snapshot's 8VC Series B participation therefore requires separate round-specific attribution review. The original historical neurotech seed remains verified regardless of later product evolution. No additional direct neurotech investment was verified in the checked sources. General AI and CNS drug-development references were not counted as direct neurotechnology. ## Conflicts, gaps and concrete Adex review notes 1. Correct the entity narrative only after review: its 1969 founding claim conflicts with the 2015 structured field; headquarters should reflect verified Austin, retaining San Francisco/New York offices separately. Signal repeats the narrative and is not an independent confirmation. 2. Distinguish Fund V $880 million, Fund VI $998 million raised, Fund VII $1.5 billion target/pre-sale snapshot and historic manager committed capital. Check Fund VII SEC amendments or an official close before treating it as raised capital. 3. Retain current check minimum/maximum as unknown unless official mandate evidence appears. Signal person ranges are stale/unverified and are not uniform across profiles. 4. Audit duplicate Wispr IDs (`Wispr`, `WisprAI`, `WisprWisprFlow`) and duplicated rounds. Existing 2026 Series B records include $30 million and $260 million amounts inconsistent with the company's $280 million announced round; some evidence references funding talks or older rounds. These are review flags, not authorized database edits. 5. The snapshot's Epirus 2025 record marks 8VC non-lead and uses 2025-03-04; the company announcement identifies a co-lead and March 5 announcement. Preserve original source dates if reporting preceded the release, but record the distinction. 6. Review snapshot investor `amount` values that equal whole company rounds, including Epirus and BigHat. No checks verified here. Existing BigHat older entries mix Series A date/amount with a Series B source; this memo verifies the separate 2026 Series C only. 7. Keep Wispr's historical neural-interface evidence alongside current voice/software classification. Do not infer current neurotech focus, clinical validation, or new neurotech activity from the 2026 round. No evidence here that 8VC is a dedicated neurotech fund. 8. This is selected substantive portfolio verification, not an audit of all 486 baseline participations. Current legal fund status, all partner titles, allocations, checks and full portfolio remain outside the verified evidence set. Every external URL above was accessed **2026-10-06**. Undated live pages have no reliable publication date; financing/article dates are stated alongside their claims. Official announcements establish issuer/firm assertions, not independently audited capital accounts or technology efficacy. No Adex edits, database writes, MCP Patch calls or commits were made.
team@apexlogos.ai1 hour ago
Match research 2026-10-06 / Firm8VC / sha256:d71c7626bfe56a833a8f42e2492f0b0569532f2fc5ecfa34d0c3864a01d0f6e4 / part 1 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. # 8VC — Firm8VC - Exact Adex ID: `Firm8VC` - Adex webpage: https://adex.page/firms/Firm8VC - Research date and source access date: **2026-10-06** - Status: Complete research memo; research only, no Adex/database changes. 8VC is an Austin-headquartered technology investment and company-building firm with verified deep-tech exposure in directed-energy systems, autonomous vessels, biological engineering and historical non-invasive neural interfaces. Its officially announced Fund VI raised $998 million in new LP capital in March 2025. A newer Fund VII has a $1.5 billion offering target in a June 2026 filing mirror, but a completed raise was not verified. Wispr establishes historical direct neurotechnology investment; its current voice products should receive a separate classification. ## Starting evidence: Adex and NFX Signal The exact-ID saved record `data/research/_sources/Firm8VC.adex.json`, retrieved 2026-10-06, was inspected first. It contains a 2015 founding field, an Austin location, null check-size fields, many team roles and 486 investment participations. Its narrative instead says founded 1969 and headquartered San Francisco. Existing investment entries include Epirus, BigHat Biosciences, Mammoth Biosciences, and multiple Wispr/Wispr AI/Wispr Flow identities. The participation count is not a count of unique investments: duplicated company/round entries and round totals in investor amount fields require review. Baseline sectors include DeepTech, AI, infrastructure, healthcare, defense and logistics; baseline source links include the official site, Signal and Goldi. These are existing claims, not independently verified data. [NFX Signal's firm page](https://signal.nfx.com/firms/8vc) was directly read (undated). It reproduces the 1969 narrative while separately displaying Founded: 2015, and shows New York as its headline location alongside numerous other locations. The accessible firm-page extraction did not reliably expose its complete team/transaction content. It is useful for discovery, not corroboration of that copied narrative. Directly read Signal profiles provide additional discovery claims: - [Denis Aven](https://signal.nfx.com/investors/denis-aven): $500,000–$30 million investment range, $16.5 million sweet spot, $880 million current fund; Seed/Series A rankings including DeepTech. - [Bela Becerra](https://signal.nfx.com/investors/isabela-becerra): $3–$30 million range, $16.5 million sweet spot, $880 million fund, Seed/A/B manufacturing and material-science rankings. Direct page labels her Partner, while search-index text still labels her Principal. - [Alex Kolicich](https://signal.nfx.com/investors/alex-kolicich): $3–$30 million range, $16.5 million sweet spot, $880 million fund; biotech and cloud Seed/A/B rankings. Individual investment list is sign-in gated and count displays differ. All three are undated, accessed 2026-10-06. Their $880 million figure matches historical Fund V rather than newer Fund VI. Their ranges are profile claims and should not become verified firm-wide ticket limits. Personal/predecessor investments visible in biographies do not establish investments by 8VC funds. ## Identity and mandate The [official about page](https://www.8vc.com/about-us) lists infrastructure IT, biology, healthcare, government/defense and logistics as thesis areas, and gives its Austin street address (undated). The [Fund V announcement](https://www.8vc.com/resources/announcing-8vc-fund-v), dated 2023-03-01, explicitly calls Austin its new headquarters, with San Francisco and New York offices. Founding field 2015 is consistent with Signal's structured field and [2025 reporting](https://techcrunch.com/2025/01/29/joe-lonsdales-8vc-seeking-1b-for-new-fund/) describing a ten-year-old firm; the narrative 1969 claim is untenable for this entity. Firm marketing sometimes includes earlier team/predecessor history, which should remain distinct from the present firm. ## Fund size and capital status | Vehicle/measure | Amount, date and status | Evidence and qualification | | --- | --- | --- | | 8VC Fund V | **US$880 million**, announced 2023-03-01 as new fund capital | [Official Fund V announcement](https://www.8vc.com/resources/announcing-8vc-fund-v). A realized fundraising announcement, not merely a target. Announcement does not specify a separate legal final-close date. | | Aggregate committed capital | **Over US$6 billion**, as of 2023-03-01 | Same announcement. Manager-wide committed capital; not Fund V size and not necessarily current NAV or current regulatory AUM. | | 8VC Fund VI | **US$998 million** new LP capital, announced 2025-03-04 | [Official Fund VI announcement](https://8vc.com/resources/announcing-8vc-fund-vi). Treat as announced raised capital; no separate final-close date identified. Latest officially announced flagship raised amount verified here. | | 8VC Fund VII, L.P. | **US$1.5 billion offering target**; June 29, 2026 initial filing reports first sale yet to occur, zero investors and no sold capital | [SEC filing index](https://www.sec.gov/Archives/edgar/data/2128986/000212898626000001/0002128986-26-000001-index.htm) confirms issuer and filing date. [FormDs mirror](https://www.formds.com/issuers/8vc-fund-vii-l-p) supplies the offering/sold fields through search-index extraction. SEC underlying HTML/XML body could not be read through this browser. Do not label $1.5 billion closed. | Searches for a newer flagship found Fund VII, not an official close announcement. [StartupDB](https://startupdb.com/organizations/8vc) claims a $1.5 billion mid-2026 close and [VCSpine](https://www.vcspine.com/firms/8vc) describes June 2026 as a close while also showing $1.50 billion **offered**. These undated aggregator claims conflict with the as-filed pre-sale evidence; neither was accepted as closure verification. The June snapshot does not establish fundraising status on October 6. A newer amendment or firm/LP confirmation remains necessary. Other similarly numbered 8VC AI and Entrepreneurs vehicles exist; their names alone do not establish that they are the flagship VII or that their capital may be added without overlap. This memo does not claim a comprehensive total of all feeder/SPV capital. No current verified firm-wide AUM or check-size mandate found. ## Investment stages The Fund V announcement says the firm supports entrepreneurs throughout their journey and describes **8VC Build**, which creates companies before traditional venture rounds. That establishes formation/company-building activity and a broad mandate, rather than exclusive seed specialization. Signal's individual Seed/A/B categories are supporting discovery evidence. Verified historical transactions here include seed (Wispr), Series C (BigHat) and Series D (Epirus). Their presence demonstrates activity across stages; it does not prove Fund VI or VII allocation rules. No official stage allocation percentages, maximum round stage or current standardized check range found. ## Named previous deep-tech investments Company-round amounts below are total financings, **not 8VC's contribution**. Except where stated, fund vehicle and investor check were not disclosed. | Company | Technology rationale | Verified firm attribution and dated evidence | | --- | --- | --- | | **Epirus** | Solid-state gallium-nitride high-power microwave arrays and intelligent power control for counter-electronics/counter-drone defense. This is physical systems/electronics engineering, not ordinary SaaS. | **8VC co-led $250 million Series D with Washington Harbour Partners**, announced **2025-03-05**. The [company-issued PR Newswire announcement](https://www.prnewswire.com/news-releases/epirus-closes-250m-series-d-to-hyperscale-leonidas-production-capability-for-critical-asset-protection-302392509.html) names both leads. The [official leadership page](https://www.epirusinc.com/leadership) (undated) says Joe Lonsdale co-founded Epirus with 8VC Build in 2018 and names 8VC partner Alex Moore as chairman. | | **BigHat Biosciences** | AI-guided protein/antibody design integrated with autonomous high-throughput biological experimentation and validation; science-intensive therapeutics platform. | **8VC participated as an existing investor in a completed $75 million Series C**, announced **2026-09-24**; DFJ Growth and Premji Invest co-led. [Official company announcement](https://www.bighatbio.com/news/bighat-biosciences-announces-75-million-series-c-financing). Company reports $223 million cumulative funding, distinct from this round. No 8VC check or fund identified. |
team@apexlogos.ai22 days ago
MATCH

Jake Medwell 8VC, Co-Founder and Partner	$16M$3M – $50M	Austin, Texas
Bela Becerra 8VC, Principal	$16M$3M – $30M	LatAm (Latin America) · Austin, Texas · New York, New York · San Francisco, California
Kimmy Scotti 8VC, Partner	$16M$3M – $30M	New York City
Alex Moore 8VC, Partner	$16M$3M – $30M	San Francisco Bay Area
Bhaskar Ghosh 8VC, Partner	$16M$3M – $30M	San Francisco Bay Area
Francisco Gimenez 8VC, Partner	$16M$3M – $30M	San Francisco Bay Area
Denis Aven 8VC, Investor	$16M$500K – $30M	San Francisco Bay Area · New York City
Alex Kolicich 8VC, Founding Partner	$16M$3M – $30M	San Francisco, California
Jin-Young Kim 8VC, Partner	$16M$3M – $30M	San Francisco, California
Justin Rose 8VC, Investment Associate	$16M$500K – $30M	San Francisco, California
Sebastian Caliri 8VC, Partner	$16M$3M – $30M	San Francisco, California
Seth Lieblich 8VC, Principal	$16M$500K – $30M	San Francisco, California
Vivek Gopalan 8VC, Principal	$16M$3M – $30M	San Francisco, California
Jack Moshkovich 8VC, Partner	$16M$3M – $30M	Stanford, California
Arthur James 8VC, Advisor	$10M$100K – $25M	Austin, Texas
Susan Liu 8VC, Investment Team	$2M$1M – $4M	San Francisco, California
John Tenet 8VC, Partner	$1M$100K – $10M	New York, New York
John Bertrand 8VC, Advisor	$250K$100K – $500K	San Francisco, California
Andres Rosales 8VC, Investment Team	$25K$5K – $100K	San Francisco, California
Ascanio Guarini 8VC, Incubations & Early-Stage Tech	$20M$1M – $100M
Aaron Levie 8VC, CEO, Box	—— – —
Adrienne Alexander 8VC, Operations	—— – —
Alan Murray 8VC, CEO and President, Empire BlueCross BlueShield‍	—— – —
Alex McLane 8VC, Investment Team	—— – —
Alicia Jackson 8VC, CTO, Drawbridge Health‍	—— – —
Andrew Perlman 8VC, Chief Medical Officer of Velocity Pharmaceutical Development	—— – —
Andrew Rubin 8VC, CEO, Illumio	—— – —
Andy Cunningham 8VC, CEO, Cunningham Collective	—— – —
Asanka Jayasuriya 8VC, Portfolio Support	—— – —
Audrey Abbott 8VC, Operations	—— – —
Ava Eitzen 8VC, Portfolio Support	—— – —
Cain McClary 8VC, Managing Partner and Founder, KdT Ventures	—— – —
Caroline Haun 8VC, Operations	—— – —
Charlie Songhurst 8VC, Investor	—— – —
Damon Lim 8VC, Operations	—— – —
Daniel Saks 8VC, President & Co-CEO, AppDirect	—— – —
David Wyler 8VC, Managing Director, Granaria Holdings	—— – —
Denise Mendez 8VC, Operations	—— – —
Deny Khoung 8VC, Portfolio Support	—— – —
Drew Oetting 8VC, Investment Team	—— – —
Eric Ly 8VC, Co-Founder, Presdo Co-Founder & CTO, LinkedIn	—— – —
Eric Poirier 8VC, CEO, Addepar	—— – —
Erica Sun 8VC, Finance/Legal/IR	—— – —
Evan Pun 8VC, Portfolio Support	—— – —
Faith Zehfuss 8VC, Investment Team	—— – —
Gabe Rosen 8VC, Portfolio Support	—— – —
Hardy Trentini 8VC, International Investor	—— – —
Ian Shannon 8VC, Finance/Legal/IR	—— – —
Jake Kloberdanz 8VC, Founder and CEO, ONEHOPE	—— – —
James Piercy 8VC, Portfolio Support	—— – —
James Stickland 8VC, CEO, Veridium	—— – —
Jane Commerford 8VC, Operations	—— – —
Joe Lonsdale 8VC, Investment Team	—— – —
Joel Hemmert 8VC, Finance/Legal/IR	—— – —
Karen White 8VC, Investment Team	—— – —
Keri Findley 8VC, Investor	—— – —
Kevin Niechen 8VC, Investment Team	—— – —
Kristen Dumont 8VC, COO, Machine Zone, Inc.	—— – —
Luke Bugbee 8VC, Portfolio Support	—— – —
Luke Zane 8VC, Portfolio Support	—— – —
Macenzie Walford 8VC, Operations	—— – —
Madison McDonald 8VC, Finance/Legal/IR	—— – —
Michael Milstein 8VC, Co-CEO and Co-President, Emigrant Bank and Milstein Properties	—— – —
Nichole Horton 8VC, Finance/Legal/IR	—— – —
Nick Penske 8VC, Investment Team	—— – —
Nima Ghamsari 8VC, CEO, Blend Labs	—— – —
Reginald McKnight 8VC, Global Head of Social Impact, Google	—— – —
Richard Weinberg 8VC, CEO, Terrace Tower Holdings	—— – —
Robin Kaufman 8VC, Operations	—— – —
Stephanie Watkins 8VC, Operations	—— – —
Stephen Condon 8VC, Finance/Legal/IR	—— – —
Sudarsan Thattai 8VC, Chief Information Officer, Lineage Logistics	—— – —
Tobey Maguire 8VC, Film Actor & Investor	—— – —
Tyler Bates-Collier 8VC, Operations	—— – —
Vero St Germain 8VC, Portfolio Support	—— – —
Vivian Bannon 8VC, FinTech Legal Innovator	—— – —
Vlad Novakovski 8VC, CEO, Elliot Technologies	—— – —
Yurie Lee 8VC, Operations	—— – —
Zach Rivkin 8VC, Co-Founder & CEO, Gatsby Labs	—— – —
Zachary Bookman 8VC, CEO, OpenGov	—— – —
Zachary White 8VC, Investment Team	—— – —
Zivan Benisty 8VC, Founder and CEO, ZCS 25 years of experience in the Israeli Intelligence Community	—— – —

Funds5

Team

Co-investing

Investments